Competition to be seen intensifying over OTC market

Published: 2012-09-03 07:00:00

Updated: 2012-09-03 07:00:00

A fierce battle is foreseen in the domestic market for over-the-counter (OTC) drugs, which has so far been neglected by local drugs makers, according to Yakup Shinmoon, a local trade paper.

To soften the government-mandated cuts in drug prices, a growing number of pharmaceutical companies are ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK